United States

Atea Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, currently in Phase II clinical trial for COVID-19 treatment. The company also develops other antiviral drugs for dengue, HCV, and other RNA viral infections. Atea has a license agreement with Merck & Co for the development and commercialization of ruzasvir for HCV treatment. The company was founded in 2012 and is based in Boston, Massachusetts.

Google

Product Manager

Data Scientist

Atea Pharmaceuticals

Atea Pharmaceuticals Ledige stillinger

Er du klar til at løfte din karriere? Tjek disse ledige stillinger hos Atea Pharmaceuticals.